Betamethasone dipropionate manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

betamethasone dipropionate

Cream 0.05 %

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #23786
Founded in the 1950s with nearly seven decades of pharmaceutical leadership, this integrated pharma company is among the top players in its home market. Rx and OTC portfolio spans branded generics, biosimilars, APIs, and novel drugs across oncology, metabolic, cardiac, and infectious disease therapy areas. US FDA and EU-GMP approved facilities operate across multiple continents.

betamethasone dipropionate

Cream 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #36540

Established in January 2010, this manufacturer specializes in the contract manufacturing of oral solid dosage forms for both pharmaceuticals and nutraceuticals. As a CTD dossier owner and manufacturer, it holds GMP approvals, ensuring compliance with international quality standards. The manufacturer operates advanced production lines for tablets, capsules, and sachets, adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in various countries worldwide. With a dedicated team experienced in formulation development, the manufacturer is committed to delivering high-quality and regulatory-compliant products

betamethasone dipropionate + betamethasone sodium phosphate

Suspension for injection 10 mg + 4 mg - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, ANVISaudi Arabia, PICS, INVIMA, Saudi Arabia
Manufacturer #11735
Indian pharmaceutical manufacturer established in the 1980s with over four decades of experience producing Rx tablets, capsules, oral liquids, ointments, and eye drops. Exports to 80+ countries across Asia, Africa, Latin America, and CIS markets. Holds WHO-GMP, EU-GMP, PIC/s, ANVISA, COFEPRIS, and DIGEMID regulatory approvals.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Betamethasone dipropionate

Betamethasone dipropionate is classified as a super high potency corticosteroid used as an anti-inflammatory or immunosuppressive agent. Betamethasone dipropionate treats a wide range of skin conditions like eczema, dermatitis, allergies, and rashes. It’s actions reduce the swelling, itching, and redness caused by these conditions. Betamethasone dipropionate is prescribed in the treatment of cutaneous T-cell lymphoma, seborrheic dermatitis that causes allergic red and itchy skin called atopic dermatitis. Also prescribed to cure contact dermatitis, inflammation of the skin due to an allergy and contact with the offensive substance, granuloma Annulare, plaque psoriasis, psoriasis of itching of the anus, itching of the genital area, scalp, skin rash that becomes thick and discolored from rubbing it, skin inflammation and itching. It is commonly used in combination with other drugs such as Luxiq, Lotrisone, and Taclonex. Betamethasone dipropionate is sold under the brand names Alphatrex, Beta-Val, and Diprolene amongst others. Merck patented Betamethasone dipropionate in 1987 was, as an augmented cream/lotion, in the U.S. and Europe. But these patents have expired since then leading to a generic production of betamethasone dipropionate by several other local manufacturers in countries around the world.

Dosage, forms, and application:

Betamethasone dipropionate is available systemically (injectable and oral) and as Topical formulations with medium to very high potency. Its cream/lotion/ointment are available in 0.05%, 0.1%, concentrations whereas the gel has only the 0.05% variant. It’s foam form has a strength of 0.12% and the spray has 0.05% of medicine per gram. In the treatment of Plaque Psoriasis, indicated for treating mild-to-moderate plaque psoriasis in adults, the patient has to apply it directly to the affected area once every 12 hours. In the treatment of Steroid-Responsive Dermatoses, the patient has to apply the ointment, cream, lotion, or gel once every 12 hours.

The price of Betamethasone dipropionate

In the USA, consumers have to pay an average retail price of $82.43 for a generic tube of cream of 45g of 0.05% concentration of this medicine. The price of this medicine is significantly cheaper in India with prices as low as USD5 for the same supply.

How does Betamethasone dipropionate work?

Betamethasone is corticosteroids. Broadly speaking, its actions activate natural substances in the skin to reduce swelling, redness, and itching. It achieves this by binding to specific intracellular glucocorticoid receptors. It then subsequently binds to DNA modifying the gene expression. The resulting synthesis induces anti-inflammatory proteins while prohibiting the synthesis of other inflammatory mediators..

Finding Betamethasone dipropionate Manufacturers and Suppliers

The best way to find and gain access to Betamethasone dipropionate manufacturers and Betamethasone dipropionate suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Betamethasone dipropionate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Betamethasone dipropionate to work with. You can fine-tune your search results using various filters too, letting you search for Betamethasone dipropionate from specific countries.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.